Kyowa Hakko Kirin Buy Of Scotland Firm Counts On Antibodies
This article was originally published in PharmAsia News
Executive Summary
Japan's Kyowa Hakko Kirin expects its recent purchase of a Scotland company to provide a sales network for antibody treatments in the United States as well as Europe